# Folia Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/folia-health

- Industry: Healthcare IT
- Headquarters: Boston, US
- Website: www.foliahealth.com
- Total disclosed funding: $11M
- Latest round: Series A (Oct 1, 2025)
- Investors on record: 3

## About

Folia Health, Inc. is a digital health company that provides an innovative platform for tracking and documenting health changes, enhancing communication among patients, caregivers, and healthcare professionals. Founded in 2016 in Boston, US, Folia Health, Inc. specializes in digital health solutions aimed at individuals with chronic conditions. The founders, Daniel Toffling and Nell Luo, have experience building health-focused technologies. In October 2025, Folia Health, Inc. raised USD 10.5 million in series A funding led by new investor S3 Ventures, with participation from other new investors Crosslink Capital and Create Health Ventures. Folia Health offers a comprehensive digital health platform centered around the Folia Health App, which allows users to document significant health changes over time. This app is particularly beneficial for individuals managing chronic conditions like eczema, providing insights based on user-reported outcomes. By consolidating health data in one platform, Folia Health seeks to enhance patient engagement and improve communication with healthcare providers. The app is designed following extensive research to improve user experience and serves a range of users, including patients, caregivers, and healthcare providers, primarily in the United States, with plans for global expansion.Folia Health's revenue model is based on direct transactions through the Folia Health App, which operates on a freemium basis. Users can access a free version to promote adoption, while premium features are available via subscription, enhancing user experience and data analysis capabilities. The pricing model includes various tiers to meet different user needs, with transactions facilitated through in-app purchases, allowing seamless upgrades. The flagship offerings aim to attract both individual users and healthcare providers, fostering partnerships that can further enhance user engagement and facilitate data collection for research. The company will use the October 2025 funding to expand its platform for collecting patient-reported data and grow research partnerships across chronic and rare conditions.

## Funding rounds

- Series A, Oct 1, 2025, $11M — Crosslink Capital, S3 Ventures, Create Health Ventures

## Investors

- Crosslink Capital (https://capitalatlas.ai/funds/crosslink-capital) — Series A
- S3 Ventures (https://capitalatlas.ai/funds/s3-ventures) — Series A
- Create Health Ventures (https://capitalatlas.ai/funds/create-health-ventures) — Series A